Pergolide Treatment for Substance Abusers - 4

This study has been completed.

Sponsor:

Collaborator:

New York State Psychiatric Institute

Information provided by:

National Institute on Drug Abuse (NIDA)

ClinicalTrials.gov Identifier:

NCT00000269

First received: September 20, 1999

Last updated: August 16, 2005

Last verified: October 1995

History of Changes

Purpose

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.

Condition	Intervention	Phase
Cocaine-Related Disorders Substance-Related Disorders	Drug: Pergolide	Phase 2


Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Pergolide Treatment for Substance Abusers

Resource links provided by NLM:

Drug Information available for: Pergolide Pergolide mesylate

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Side effects
Craving
Drug use
Improvement in functioning
Tolerability


Estimated Enrollment:	0
Study Start Date:	October 1995
Estimated Study Completion Date:	December 2001

Eligibility


Ages Eligible for Study:	18 Years to 55 Years (Adult)
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000269

Locations


United States, New York
New York State Psychiatric Institute
New York, New York, United States, 10032

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

New York State Psychiatric Institute

Investigators


Principal Investigator:	Herbert Kleber, M.D.	New York State Psychiatric Institute

More Information


ClinicalTrials.gov Identifier:	NCT00000269 History of Changes
Other Study ID Numbers:	NIDA-09236-4 P50-09236-4
Study First Received:	September 20, 1999
Last Updated:	August 16, 2005
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:


Disease Substance-Related Disorders Cocaine-Related Disorders Pathologic Processes Chemically-Induced Disorders Mental Disorders	Pergolide Dopamine Agonists Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs

ClinicalTrials.gov processed this record on September 30, 2016

To Top